Serina Therapeutics, Inc. Capital Expenditures
Serina Therapeutics, Inc. (SER) reported Capital Expenditures of $53.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- Serina Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $28.00K, a 39.13% decline year-over-year.
- Serina Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $25.00K.
- Serina Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Serina Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $13.00K, a 333.33% increase year-over-year.
- Serina Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $59.00K, a 168.18% increase from fiscal 2024.
- Serina Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $22.00K.
- Serina Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2020 was $20.00K, a 96.88% decline from fiscal 2019.
- Serina Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2019 was $641.00K, a 2952.38% increase from fiscal 2018.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $53.00K 10-Q · filed 2026-08-13 | $53.00K derived: sum of 3 quarters · filed 2026-08-13 | $66.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $25.00K 10-Q · filed 2026-05-14 | $25.00K derived: sum of 2 quarters · filed 2026-05-14 | $38.00K derived: sum of 3 quarters · filed 2026-05-14 | $84.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $13.00K derived: sum of 2 quarters · filed 2026-03-25 | $59.00K derived: sum of 3 quarters · filed 2026-08-13 | $59.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $59.00K derived: sum of 2 quarters · filed 2026-08-13 | $59.00K 10-Q · filed 2025-11-13 | $64.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $46.00K 10-Q · filed 2026-08-13 | $51.00K derived: sum of 3 quarters · filed 2026-08-13 | $54.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $5.00K derived: sum of 2 quarters · filed 2026-05-14 | $8.00K derived: sum of 3 quarters · filed 2026-05-14 | $8.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $8.00K derived: sum of 2 quarters · filed 2026-03-25 | $8.00K derived: sum of 3 quarters · filed 2026-03-25 | $22.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.00K derived: sum of 2 quarters · filed 2025-11-13 | $17.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $14.00K 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $14.00K 10-Q · filed 2025-05-08 | |||
| 2023-09-30 | $119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $434.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $315.00K 10-Q · filed 2024-08-09 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $12.00K derived: sum of 2 quarters · filed 2022-03-29 | $16.00K derived: sum of 3 quarters · filed 2022-03-29 | $20.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $16.00K derived: sum of 2 quarters · filed 2021-11-12 | $20.00K 10-Q · filed 2021-11-12 | $315.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $8.00K 10-Q · filed 2021-08-13 | $303.00K derived: sum of 3 quarters · filed 2021-08-13 | $540.00K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $4.00K 10-Q · filed 2021-05-17 | $299.00K derived: sum of 2 quarters · filed 2021-05-17 | $536.00K derived: sum of 3 quarters · filed 2021-05-17 | $642.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $532.00K derived: sum of 2 quarters · filed 2021-03-31 | $638.00K derived: sum of 3 quarters · filed 2021-03-31 | $641.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $237.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $343.00K derived: sum of 2 quarters · filed 2020-11-16 | $346.00K 10-Q · filed 2020-11-16 | $346.00K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $109.00K 10-Q · filed 2020-08-14 | $109.00K derived: sum of 3 quarters · filed 2020-08-14 | $117.00K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $3.00K 10-Q · filed 2020-05-14 | $3.00K derived: sum of 2 quarters · filed 2020-05-14 | $11.00K derived: sum of 3 quarters · filed 2020-05-14 | $23.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-31 | $8.00K derived: sum of 2 quarters · filed 2020-03-31 | $20.00K derived: sum of 3 quarters · filed 2020-03-31 | $21.00K 10-K/A · filed 2020-03-31 |
| 2018-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $20.00K derived: sum of 2 quarters · filed 2019-11-14 | $21.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $13.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $1.00K 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | $1.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |